Perform Another (Advanced) Search

1.  CenterWatch: Clinical Trials in Category (789) Osteosarcoma
...CenterWatch: Clinical Trials in Category (789) Osteosarcoma Osteosarcoma State • California • Virginia California Duarte : City of Hope New! COG AOST0331: A Randomized Trial of ...
View Page

2.  Study Posting (713) Trial #135056, Osteosarcoma, Charlottesville, VA
...Study Posting (713) Trial #135056, Osteosarcoma, Charlottesville, VA Trial Information Children and young adults with osteosarcoma sought for research study. The Cancer Center at the University of Virginia Health System invites ...
View Page

3.  Study Posting (2246) Trial #109595, Osteosarcoma, Duarte, CA
...Study Posting (2246) Trial #109595, Osteosarcoma, Duarte, CA Trial Information COG AOST0331: A Randomized Trial of the European and American Osteosarcoma Study Group to Optimize Treatment Strategies for Resectable Osteosarcoma Based on Histological Response to Pre ...
View Page

4.  Study Posting (1918) Trial #159854, Sarcoma, Savannah, GA
...GA Trial Information Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma RATIONALE: Collecting and storing samples of tumor tissue and blood from patients to test in ...
...study is to collect and store samples of blood and tumor tissue from patients with osteosarcoma. DISEASE CHARACTERISTICS: • All osteosarcoma patients seen at COG institutions are eligible, including the following: • Newly ...
View Page

5.  Study Posting (1918) Trial #160122, Sarcoma, Savannah, GA
...GA Trial Information Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma COG AOST0331 RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth ...
...2b is more effective than two different combination chemotherapy regimens alone after surgery in treating osteosarcoma. PURPOSE: This randomized phase III trial is studying combination chemotherapy followed by surgery and two ...
View Page

6.  Study Posting (2246) Trial #140343, Sarcoma, Duarte, CA
...Factor-1 Receptor for the Treatment of Patients with Recurrent or Refractory Ewing's Sarcoma, Osteosarcoma, Synovial Sarcoma, Rhabdomyosarcoma and Other Sarcomas You have/your child has been asked to participate ...
...is no longer curable by surgery or standard therapy. Eligible diagnoses include Ewing’s sarcoma, osteosarcoma, synovial sarcoma, rhabdomyosarcoma and subtypes alveolar soft part sarcoma, desmoplastic small round cell tumor, extraskeletal ...
View Page

7.  Newly Approved Drug Therapies (1064) Fusilev (levoleucovorin), Spectrum Pharmaceuticals,
...Status: Approved March of 2008 Treatment Area: For rescue after high-dose methotrexate therapy in osteosarcoma and to reduce the toxicity of methotrexate General Information Fusilev is a folate analog injection ...
...metabolic block effected by methotrexate. Fusilev is specifically indicated after high-dose methotrexate therapy in osteosarcoma and to diminish the toxicity and counteract the effects of impaired methotrexate elimination and of ...
View Page

8.  Study Posting (4519) Trial #131688, Sarcoma, Manchester, United Kingdom
...Factor-1 Receptor for the treatment of patients with recurrent or refractory Ewing's sarcoma, osteosarcoma, synovial sarcoma, rhabdomyosarcoma and other sarcomas. Brief Summary: This single arm study will evaluate the ...
...refractory sarcoma. Five cohorts of sarcoma patients will be studied in parallel: Ewing's sarcoma, osteosarcoma, synovial sarcoma, rhabdomyosarcoma, and other sarcomas. All patients will receive R1507 9mg/kg i.v ...
View Page

9.  Study Posting (4519) Trial #131640, Sarcoma, London, United Kingdom
...Factor-1 Receptor for the treatment of patients with recurrent or refractory Ewing's sarcoma, osteosarcoma, synovial sarcoma, rhabdomyosarcoma and other sarcomas. Brief Summary: This single arm study will evaluate the ...
...refractory sarcoma. Five cohorts of sarcoma patients will be studied in parallel: Ewing's sarcoma, osteosarcoma, synovial sarcoma, rhabdomyosarcoma, and other sarcomas. All patients will receive R1507 9mg/kg i.v ...
View Page

10.  Study Posting (4519) Trial #131828, Sarcoma, Birmingham, United Kingdom
...Factor-1 Receptor for the treatment of patients with recurrent or refractory Ewing's sarcoma, osteosarcoma, synovial sarcoma, rhabdomyosarcoma and other sarcomas. Brief Summary: This single arm study will evaluate the ...
...refractory sarcoma. Five cohorts of sarcoma patients will be studied in parallel: Ewing's sarcoma, osteosarcoma, synovial sarcoma, rhabdomyosarcoma, and other sarcomas. All patients will receive R1507 9mg/kg i.v ...
View Page

11.  Study Posting (4519) Trial #131805, Sarcoma, Stockholm, Sweden
...Factor-1 Receptor for the treatment of patients with recurrent or refractory Ewing's sarcoma, osteosarcoma, synovial sarcoma, rhabdomyosarcoma and other sarcomas. Brief Summary: This single arm study will evaluate the ...
...refractory sarcoma. Five cohorts of sarcoma patients will be studied in parallel: Ewing's sarcoma, osteosarcoma, synovial sarcoma, rhabdomyosarcoma, and other sarcomas. All patients will receive R1507 9mg/kg i.v ...
View Page

12.  Study Posting (4519) Trial #131876, Sarcoma, Lund, Sweden
...Factor-1 Receptor for the treatment of patients with recurrent or refractory Ewing's sarcoma, osteosarcoma, synovial sarcoma, rhabdomyosarcoma and other sarcomas. Brief Summary: This single arm study will evaluate the ...
...refractory sarcoma. Five cohorts of sarcoma patients will be studied in parallel: Ewing's sarcoma, osteosarcoma, synovial sarcoma, rhabdomyosarcoma, and other sarcomas. All patients will receive R1507 9mg/kg i.v ...
View Page

13.  Study Posting (4519) Trial #131848, Sarcoma, Palma de Mallorca, Spain
...Factor-1 Receptor for the treatment of patients with recurrent or refractory Ewing's sarcoma, osteosarcoma, synovial sarcoma, rhabdomyosarcoma and other sarcomas. Brief Summary: This single arm study will evaluate the ...
...refractory sarcoma. Five cohorts of sarcoma patients will be studied in parallel: Ewing's sarcoma, osteosarcoma, synovial sarcoma, rhabdomyosarcoma, and other sarcomas. All patients will receive R1507 9mg/kg i.v ...
View Page

14.  Study Posting (4519) Trial #131646, Sarcoma, Madrid, Spain
...Factor-1 Receptor for the treatment of patients with recurrent or refractory Ewing's sarcoma, osteosarcoma, synovial sarcoma, rhabdomyosarcoma and other sarcomas. Brief Summary: This single arm study will evaluate the ...
...refractory sarcoma. Five cohorts of sarcoma patients will be studied in parallel: Ewing's sarcoma, osteosarcoma, synovial sarcoma, rhabdomyosarcoma, and other sarcomas. All patients will receive R1507 9mg/kg i.v ...
View Page

15.  Study Posting (4519) Trial #131644, Sarcoma, Barcelona, Spain
...Factor-1 Receptor for the treatment of patients with recurrent or refractory Ewing's sarcoma, osteosarcoma, synovial sarcoma, rhabdomyosarcoma and other sarcomas. Brief Summary: This single arm study will evaluate the ...
...refractory sarcoma. Five cohorts of sarcoma patients will be studied in parallel: Ewing's sarcoma, osteosarcoma, synovial sarcoma, rhabdomyosarcoma, and other sarcomas. All patients will receive R1507 9mg/kg i.v ...
View Page

16.  Study Posting (4519) Trial #131643, Sarcoma, Oslo, Norway
...Factor-1 Receptor for the treatment of patients with recurrent or refractory Ewing's sarcoma, osteosarcoma, synovial sarcoma, rhabdomyosarcoma and other sarcomas. Brief Summary: This single arm study will evaluate the ...
...refractory sarcoma. Five cohorts of sarcoma patients will be studied in parallel: Ewing's sarcoma, osteosarcoma, synovial sarcoma, rhabdomyosarcoma, and other sarcomas. All patients will receive R1507 9mg/kg i.v ...
View Page

17.  Study Posting (4519) Trial #131696, Sarcoma, Rotterdam, Netherlands
...Factor-1 Receptor for the treatment of patients with recurrent or refractory Ewing's sarcoma, osteosarcoma, synovial sarcoma, rhabdomyosarcoma and other sarcomas. Brief Summary: This single arm study will evaluate the ...
...refractory sarcoma. Five cohorts of sarcoma patients will be studied in parallel: Ewing's sarcoma, osteosarcoma, synovial sarcoma, rhabdomyosarcoma, and other sarcomas. All patients will receive R1507 9mg/kg i.v ...
View Page

18.  Study Posting (4519) Trial #131986, Sarcoma, Milano, Italy
...Factor-1 Receptor for the treatment of patients with recurrent or refractory Ewing's sarcoma, osteosarcoma, synovial sarcoma, rhabdomyosarcoma and other sarcomas. Brief Summary: This single arm study will evaluate the ...
...refractory sarcoma. Five cohorts of sarcoma patients will be studied in parallel: Ewing's sarcoma, osteosarcoma, synovial sarcoma, rhabdomyosarcoma, and other sarcomas. All patients will receive R1507 9mg/kg i.v ...
View Page

19.  Study Posting (4519) Trial #131797, Sarcoma, Bologna, Italy
...Factor-1 Receptor for the treatment of patients with recurrent or refractory Ewing's sarcoma, osteosarcoma, synovial sarcoma, rhabdomyosarcoma and other sarcomas. Brief Summary: This single arm study will evaluate the ...
...refractory sarcoma. Five cohorts of sarcoma patients will be studied in parallel: Ewing's sarcoma, osteosarcoma, synovial sarcoma, rhabdomyosarcoma, and other sarcomas. All patients will receive R1507 9mg/kg i.v ...
View Page

20.  Study Posting (4519) Trial #132028, Sarcoma, Tübingen, Germany
...Factor-1 Receptor for the treatment of patients with recurrent or refractory Ewing's sarcoma, osteosarcoma, synovial sarcoma, rhabdomyosarcoma and other sarcomas. Brief Summary: This single arm study will evaluate the ...
...refractory sarcoma. Five cohorts of sarcoma patients will be studied in parallel: Ewing's sarcoma, osteosarcoma, synovial sarcoma, rhabdomyosarcoma, and other sarcomas. All patients will receive R1507 9mg/kg i.v ...
View Page